Bibliography

 

Hafizi S., Serres F., Pei Q., Totterdell S., Sharp T. (2011) Evidence for colocalisation between the 5HT and NK1 receptors. Journal of Psychopharmacology, Nov5.

Serres F., Rodriguez M., Rivet J.M., Galizzi J.P., Lockart B. , Sharp T., Millan M.J. (2011) Blockade of alpha-2 adrenoceptors induces Arc gene expression in rat brain in a glutamate-dependent manner: a combined qPCR, in situ hybridisation and immunocytochemistry study. Revised in Neuropharmacology.

Millan M.J., Dekeyne A., Brocco M.,Loiseau F., Gobert A., Rivet J.M., DiCara B., Cremers T.I., Flick G., Fone K.C.F., Watson D.J.G., Papp M., Sharp T., Serres F., Cespuglio R., Olivier B., Chan J.S.W., Lavielle G. (2011) S32212, a novel 5HT2C receptor inverse agonist/alpha2-adrenoceptor antagonists and potential antidepressant: II. A behavioural, neurochemical and electrophysiological characterization,  JPET .

 Serres F., Millan M.J., Sharp T (2011) Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α2-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared with the SNRI, venlafaxine. International Journal of Neuropsychopharmacology: May 17, 1-13.

 Elizalde N., Pastor P.M., Garcia A., Serres F., Venzala E., Huarte J., Del Rio J., Sharp T and Tordera R.M.(2010) Regulation of synaptic proteins by decreased VGLUT1 levels and chronic mild stress. Journal of Neurochemistry;114(5):1302-14.

 Dekeyne A, Mannoury la Cour C, Gobert A, Brocco M, Lejeune F, Serres F, Sharp T, Daszuta A, Soumier A, Papp M, Rivet JM, Flik G, Cremers TI, Muller O, Lavielle G, Millan MJ. (2008) S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.Psychopharmacology (Berl);199(4):549-68.

 Serres F., Carney S.L. (2006) Nicotine regulates the proliferation of the neuroblastoma cells SH-SY5Y through the release of brain-derived neurotrophic factor (BDNF). Brain Research 1101(1):36-42.

 Serres F, Sartori S.B, Halton A, Pei Q, Rochat C, Singewald N, Sharp T, Millan M (2005) Stereoselective and region-specific induction of immediate early gene expression in rat parietal cortex by blockade of neurokinin-1 receptors. Journal of Psychopharmacology, 20(4):570-6.

 Millan MJ, Brocco M, Papp M,  Serres F, Drieu La Rochelle C, Sharp T, Peglion JP, Dekeyne A (2004) S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: III. Actions in Models of Potential Antidepressive and Anxiolytic Activity in comparison with Ropinirol Journal of  Pharmacology and Experimental Therapeutics 309, 936-950.

 Serres F., Sharp T The NK1-Receptor antagonist GR205171 increases the expression of Narp mRNA in the rat basolateral amygdala. In preparation

Serres F., Carney S.L. Nicotine causes an elevation of TrkB mRNA in neuroblastoma cells. Submitted to Brain Research

 L.D. Van de Kar, A. Javed, Y. Zhang, F. Serres, D.K. Raap, T.S. Gray  (2001) 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin and prolactin release and activate hypothalamic CRF and oxytocin expressing cells. Journal of Neuroscience 21(10), 3572-3579.

 Serres F., Muma N.A., Raap D., Garcia F., Battaglia G., Van de Kar L.D. (2000) Coadministration of 5-hydroxytryptamine (1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus Journal of  Pharmacology and Experimental Therapeutics, 294(1), 296-301.

 Serres F., Li Q., Garcia F., Raap D.K., Battaglia G., Muma N.A., Van de Kar L.D.  (2000) Evidence that Gz-proteins couple to hypothalamic 5-HT1A receptors in vivo. Journal of Neuroscience 20(9), 3095-3103.

 Zhang Y., Raap D., Garcia F., Serres F., Ma Q., Battaglia G., Van de Kar L.D. (2000) Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats. Brain Research, 855(1): 58-66.

 Serres F., Azorin J.M. Valli M., Jeanningros R. (1999) Evidence for an increase in functional platelet 5-HT2A receptors in depressed patients using [125I]-DOI. European Psychiatry, 14(8), 451-457.

 Richard M.A., Serres F., Giravalli P., Noe C., Grob J.J., Hesse S., Bonerandi J.J., Jeanningros R. (1998) Plasma tryptophan bioavailability during chronic urticaria. Annales of Dermatologie & Venerology 125(3), 167-170.

 Serres F., Dassa D., Azorin J.M., Jeanningros R. (1997) Red blood cell L-tryptophan uptake in depression. II: Effect of an antidepressant treatment. Psychiatry Research, 66, 87-96.

 Jeanningros R., Serres F., Dassa D., Azorin J.M., Grignon S. (1996) Red blood cell L-tryptophan uptake in depression. I. Kinetic analysis in untreated depressed patients and healthy subjects. Psychiatry Research, 63, 151-159.

 Serres F., Dassa D., Azorin J.M, Jeanningros R. (1995) Decrease in red blood cell L-tryptophan uptake in schizophrenic patients : Possible link with loss of impulse control  Progress in Neuro-Psychopharmacology & Biological Psychiatry, 19, 903-913.